Vadim S. Koshkin, MD, on Sequencing Enfortumab Vedotin With ICI for Advanced Bladder Cancer
MedPage Today,
This Reading Room is a collaboration between MedPage Today® and: Does the last systemic therapy given prior to enfortumab…
Enfortumab vedotin (EV) outcomes with and without immediate prior immune checkpoint inhibitor (ICI) in patients (pts) with advanced urothelial carcinoma (aUC).
Overview of attention for article published in Journal of Clinical Oncology, February 2023
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
Good Attention Score compared to outputs of the same age (76th percentile)
-
Average Attention Score compared to outputs of the same age and source
Readers on
- mendeley
- 2 Mendeley